• X
FreeOx
  • ABOUT
  • TEAM
  • PIPELINE
  • PARTNERSHIPS
  • NEWS
  • CONTACT US
Select Page
FreeOx opens funding round of €2,5 million to finance ischemic stroke therapy

FreeOx opens funding round of €2,5 million to finance ischemic stroke therapy

by freeoxbio-admin | Oct 15, 2025 | News

FreeOx has developed the first cerebroprotective therapy designed to preserve the brain during acute ischemic stroke. It is the key piece in stroke treatment, as it focuses on microcirculation and solves the problem of reperfusion. Its annual market potential exceeds...
Exciting News: Ox-01 Featured on the Cover of Stroke!

Exciting News: Ox-01 Featured on the Cover of Stroke!

by freeoxbio-admin | Apr 14, 2025 | News

We are thrilled to share that our pioneering stroke treatment, Ox-01 (uric acid co-crystal), has been highlighted on the cover of Stroke magazine. This recognition is a testament to the innovative work being done through the Stroke Preclinical Assessment Network...
FreeOx Biotech Celebrates Landmark 2024 with Record Growth: New Hires, Groundbreaking Trial Selections, and Major Funding Milestones

FreeOx Biotech Celebrates Landmark 2024 with Record Growth: New Hires, Groundbreaking Trial Selections, and Major Funding Milestones

by freeoxbio-admin | Mar 4, 2025 | News

Innovative Biotech Company Expands Executive Team with Three C-Suite Appointments and Advances Pipeline with Key Trial Evaluations BARCELONA and PALO ALTO, Feb. 13, 2025 /PRNewswire-PRWeb/ — FreeOx Biotech, a clinical-stage biopharmaceutical company pioneering a...
Ox-01 neuroprotective candidate selected for evaluation in new US NINDS programme

Ox-01 neuroprotective candidate selected for evaluation in new US NINDS programme

by freeoxbio-admin | Nov 20, 2024 | News

FreeOx Biotech FreeOx Biotech has announced that its uric acid-based leading compound, Ox-01, has been officially selected by the US National Institute of Neurological Disorders and Stroke (NINDS) to be evaluated on its new stroke-dedicated StrokeNet Thrombectomy...
FreeOx’s Ox-01 to be Evaluated as Adjunct Mechanical Thrombectomy Therapy for Stroke in NINDS-Funded Phase 2/3 Clinical Trial on Stroke-dedicated STEP Platform

FreeOx’s Ox-01 to be Evaluated as Adjunct Mechanical Thrombectomy Therapy for Stroke in NINDS-Funded Phase 2/3 Clinical Trial on Stroke-dedicated STEP Platform

by freeoxbio-admin | Nov 18, 2024 | News

FreeOx Biotech FreeOx’s Ox-01 Outperforms 3 Candidates from Big Pharma; Phase 2/3 Expected to Initiate in 2025 BARCELONA / PALO ALTO, Spain, Nov. 15, 2024 /PRNewswire-PRWeb/ — FreeOx Biotech, a clinical stage biopharmaceutical company pioneering the...
« Older Entries
  • X
© 2023 FREEOX • Terms of use • Privacy policy • Cookies policy
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}